発作性上室性頻拍(Paroxysmal Ventricular Tachycardia)治療薬市場2015:上市品分析、API(原薬)メーカー分析、世界市場規模

◆英語タイトル:Paroxysmal Ventricular Tachycardia-API Insights, 2015
◆商品コード:DII2015API367
◆発行会社(リサーチ会社):DelveInsight
◆発行日:2015年版(※最新版はお問い合わせください)
◆ページ数:約60
◆レポート形式:英語 / PDF
◆納品方法:Eメール(納品まで約3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、発作性上室性頻拍(Paroxysmal Ventricular Tachycardia)治療薬市場について調査・分析し、申請タイプ別上市品の詳細、市販状況別上市品の詳細、APIメーカーの分析、世界販売量予測、上市品別の市場情報、中止された医薬品情報などを以下の構成でお届けいたします。※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。

・上市品の分析
-アプリケーション(申請)タイプ別上市品の詳細
-マーケティング(市販)状況別上市品の詳細
-特許権存続期間別上市品の分析
・API(医薬品有効成分)メーカーの分析
 -米国DMF(ドラッグマスターファイル)状況別APIメーカー
 -米国DMF(ドラッグマスターファイル)状況別APIメーカー(Drug Specific)
・上市品の世界販売量予測データ
・上市品別の情報
 -医薬品の説明
 -医薬品の承認状況
 -グローバルAPIメーカー
 -特許及び独占権(Exclusivity)状況
 -企業概要
・中止された医薬品情報
【レポートの概要】

Summary

DelveInsight’s, Paroxysmal Ventricular Tachycardia-API Insights, 2015,report provides Paroxysmal Ventricular Tachycardia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Paroxysmal Ventricular Tachycardia. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Paroxysmal Ventricular Tachycardia drugs till 2016.
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.
Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

• A snapshot of the global Market therapeutics scenario for Paroxysmal Ventricular Tachycardia.
• A review of the marketed products under prescription for Paroxysmal Ventricular Tachycardia, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Paroxysmal Ventricular Tachycardia with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Paroxysmal Ventricular Tachycardia drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Paroxysmal Ventricular Tachycardia drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2012-2016.


【レポートの目次】

Table of Contents
• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Forecasted Sales Figures (2012-2016)
• Marketed Drugs Information
• Drugs Description
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Discontinued Drugs Information

List of Tables
Paroxysmal Ventricular Tachycardia Therapeutic Market, US, Marketed Drugs by Application Type, 2015
Paroxysmal Ventricular Tachycardia Therapeutic Market, US, Marketed Drugs by Marketing Status, 2015
Paroxysmal Ventricular Tachycardia Therapeutic Market, US, (Year), 2015
Paroxysmal Ventricular Tachycardia Marketed Drugs, API Manufacturers by US DMF Status, 2015
Paroxysmal Ventricular Tachycardia Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Paroxysmal Ventricular Tachycardia Therapeutic Market, Global Sales (in million USD), 2015
Paroxysmal Ventricular Tachycardia Marketed Drugs, API Manufacturers, Global, 2015
Discontinued Drugs for Paroxysmal Ventricular Tachycardia, 2015


List of Figures
Paroxysmal Ventricular Tachycardia Therapeutic Market, US, Marketed Drugs by Application Type (%), 2015
Paroxysmal Ventricular Tachycardia Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2015
Paroxysmal Ventricular Tachycardia Therapeutic Market, US, (Year), 2015
Paroxysmal Ventricular Tachycardia Marketed Drugs, API Manufacturers by US DMF Status (%), 2015
Paroxysmal Ventricular Tachycardia Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Paroxysmal Ventricular Tachycardia Therapeutic Market, Global Sales (in million USD), 2015
Paroxysmal Ventricular Tachycardia Marketed Drugs, Patent/Exclusivity Expiry (Year), 2015


【レポートのキーワード】

発作性上室性頻拍(Paroxysmal Ventricular Tachycardia)、治療薬、上市品、API(原薬)メーカー、製薬、医薬品、市販、DMF(ドラッグマスターファイル)、承認、申請、市場規模

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 発作性上室性頻拍(Paroxysmal Ventricular Tachycardia)治療薬市場2015:上市品分析、API(原薬)メーカー分析、世界市場規模(Paroxysmal Ventricular Tachycardia-API Insights, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆